Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertension: HELP
Markus P. Schlaich
Based on 115 articles published since 2007
||||
Expertise Level
The expertise of Markus P. Schlaich ranks in the
  • Top 0.0093%
  • ... of 183,560 published authors worldwide on Hypertension
  • ... from 2007 through 2018
  • ... based on contributions to 115 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Schlaich, M   ·   Schlaich, Markus P   ·   Schlaich, Markus   ·   Schlaich, M P
Work Locations
Details
Most likely:    University of Western Australia      
2018
  • From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · Pubmed 29158358
2017
  • From the Dobney Hypertension Centre, School of Medicine (M.P.S., O.A.), Department of Cardiology (M.P.S.), and Department of Nephrology (M.P.S.), Royal Perth Hospital Unit, University of Western Australia; and Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.P.S., Y.S.). · From the Dobney Hypertension Centre, School of Medicine (M.P.S., O.A.), Department of Cardiology (M.P.S.), and Department of Nephrology (M.P.S.), Royal Perth Hospital Unit, University of Western Australia; and Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.P.S., Y.S.). · Pubmed 29061721
  • From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 29038200
  • Dobney Hypertension Centre, Faculty of Health and Medical Sciences, School of Medicine-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Department of Nephrology, Royal Perth Hospital, Perth, Australia. · Dobney Hypertension Centre, Faculty of Health and Medical Sciences, School of Medicine-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Department of Nephrology, Royal Perth Hospital, Perth, Australia. · Dobney Chair in Clinical Research, School of Medicine and Pharmacology - Royal Perth Hospital Unit, The University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia. · Pubmed 28349377
  • Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Pubmed 28231948
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Heart Centre Alfred Hospital, Melbourne, Victoria, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia. · Pubmed 27604660
  • The Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Central Clinical School, Faculty of Medicine, Monash University, Melbourne, VIC, Australia. · The Human Neurotransmitters Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Department of Physiology, Monash University, Melbourne, VIC, Australia. · Neurovascular Hypertension & Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. · Neuropharmacology Laboratories, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC, Australia. · The Department of Pharmacology, Monash University, Melbourne, VIC, Australia. · Pubmed 27046647
2016
  • aDobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Western Australia bDepartment of Cardiology, Royal Perth Hospital and Fiona Stanley Hospital, Perth cNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 27356001
  • Dobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth. · Dobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth; Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth; Department of Cardiology, Royal Perth Hospital, Perth, Australia. Electronic address: · Pubmed 27671866
  • School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Western Australia, Australia; · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; and. · Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 27630063
  • Department of Medical Science, Internal Medicine Ward and Hypertension Centre Azienda Ospedaliera, Treviglio, BG, Italy. · Dobney Hypertension Centre School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia. · Dobney Hypertension Centre School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia. · Pubmed 26781253
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · The Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · William Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK. · Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Cardiology, University of Giessen, Giessen, Germany. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Department of Nephrology and Hypertension, University Hospital of Erlangen, Erlangen, Germany. · Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Cardiology, Heartcenter Catharina Hospital, Eindhoven, The Netherlands. · Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Cardiovascular Research Centre, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia. · Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 27105858
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Atherosclerosis & Vascular Biology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neuropharmacology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. Electronic address: · Pubmed 26432488
  • Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia Baker IDI Heart and Diabetes Institute, Melbourne, Australia · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia. · Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia. · School of Medicine and Pharmacology, Royal Perth Hospital Unit, The University of Western Australia, Australia. · Discipline of General Practice, University of Adelaide, Australia. · Departments of Medicine and Cardiology, The University of Melbourne, Austin Health, Australia. · Geelong Cardiology Research Department, Deakin University, Australia. · School of Medicine, University of Queensland, Brisbane, Australia. · Novartis Pharmaceuticals Australia Ltd, Sydney, Australia. · Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 26088568
2015
  • School of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Electronic address: · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 25620017
2017
  • From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · Pubmed 27956575
  • aUniversitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, GermanybDepartment of Medicine, University of Milano-Bicocca, ItalycDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, PolanddHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, SpaineFaculty of Medicine, Monash University, Baker IDI Heart and Diabetes Institute, Melbourne and Dobney Hypertension Centre, School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliafDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanygInstitute of Cardiovascular Science, University College London, London, UK. · Pubmed 27906840
2016
  • aUniversitätskliniken des Saarlandes und Universität des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany bUniversitätsklinik für Innere Medizin II, Kardiologie, Internistische Intensivmedizin und Notaufnahme, SALK - Paracelsus Universität Salzburg, Salzburg, Austria cDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland dHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain eDobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia fMedtronic, Santa Rosa, California, USA gUniversität Erlangen-Nürnberg, Medizinische Klinik 4, Nürnberg, Germany hInstitute of Cardiovascular Science and NHR Biomedical Research Centre, University College London, London, UK iKlinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, Germany jDepartment of Cardiology and Angiology, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Freiburg, Germany kCentro di Fisiologia Clinica e Ipertensione, University of Milano-Bicocca, Milan, Italy. · Pubmed 27755390
2015
  • aHypertension-24 h ABPM ESH Center of Excellence, Papageorgiou Hospital, Aristotle University Thessaloniki, Greece bDepartment of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden cDepartment of Health Science, University of Milano-Bicocca, Milano, Italy and Istituto di Ricerche a Carattere Scientifico Multimedica IRCCS, Sesto San Giovanni, Milan dIstituto Auxologico Italiano, Milano, Italy eUniversity of Valencia and INCLIVA Research Institute and CIBERobn, Madrid, Spain fExperimental and Clinical Research Center, Kooperation zwischen dem Max-Delbrück-Centrum für Molekulare Medizin und der Medizinischen Fakultät der Charité, Berlin gAbteilung für Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen hInstitute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany i1st Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, Greece jDepartment of Medicine, Debrecen University, Hungary kSchool of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 26103132
  • School of Medicine and Pharmacology - Royal Perth Hospital Unit, The University of Western Australia, Level 3 MRF Building, Rear 50 Murray Street, Perth, WA, 6000 MDBP: M570, Australia, · Pubmed 26070453
  • aHuman Neurotransmitters bNeurovascular Hypertension and Kidney Disease cNeuropharmacology Laboratories, Baker IDI Heart and Diabetes Institute dFaculty of Medicine, Nursing and Health Sciences eDepartment of Physiology fPrimary Care Research, Monash University, Melbourne gRoyal Perth Hospital Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 26259120
  • aMenzies Institute for Medical Research, University of Tasmania, Hobart bBaker IDI Heart and Diabetes Institute, Melbourne cMonash University, Clayton, Victoria dEndocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland eSchool of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth fCentre for Research in Evidence Based Practice, Bond University, Queensland, Australia. · Pubmed 26136205
  • From the Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany (M.B., F.M, C.U.); Department of Internal Medicine II, Paracelsus University Salzburg, Salzburg, Austria (U.C.H.);Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (K.N.); Global Clinical Research, Coronary and Structural Heart Disease Management, Medtronic Inc, Santa Rosa, CA (M.N.); Institute of Research & Hypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain (L.R.); School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia (M.P.S.); Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany (R.E.S.); Cardiovascular Research Centre, Interventional Cardiology, St. Vincent's Hospital, Melbourne, Australia (R.W.); Institute of Cardiovascular Sciences, University College London (UCL), National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, United Kingdom (B.W.); Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, Germany (U.Z.); Department of Cardiology and Angiology I, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Freiburg, Germany (A.Z.); and IRCCS Istituto Auxologico Italiano, Center of Epidemiology and Clinical Trials, University of Milano-Bicocca, Milan, Italy (G.M.). · From the Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany (M.B., F.M, C.U.); Department of Internal Medicine II, Paracelsus University Salzburg, Salzburg, Austria (U.C.H.);Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (K.N.); Global Clinical Research, Coronary and Structural Heart Disease Management, Medtronic Inc, Santa Rosa, CA (M.N.); Institute of Research & Hypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain (L.R.); School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia (M.P.S.); Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany (R.E.S.); Cardiovascular Research Centre, Interventional Cardiology, St. Vincent's Hospital, Melbourne, Australia (R.W.); Institute of Cardiovascular Sciences, University College London (UCL), National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, United Kingdom (B.W.); Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, Germany (U.Z.); Department of Cardiology and Angiology I, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Freiburg, Germany (A.Z.); and IRCCS Istituto Auxologico Italiano, Center of Epidemiology and Clinical Trials, University of Milano-Bicocca, Milan, Italy (G.M.). · Pubmed 25691618
  • Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Campus, University of Western Australia, Perth, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. · Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. Electronic address: · Pubmed 25638699
Probable:    Swinburne University of Technology      
2018
  • From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · Pubmed 29158358
Probable:    Baker IDI Heart and Diabetes Institute      
2017
  • From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 29038200
  • Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Pubmed 28231948
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Heart Centre Alfred Hospital, Melbourne, Victoria, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia. · Pubmed 27604660
  • The Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Central Clinical School, Faculty of Medicine, Monash University, Melbourne, VIC, Australia. · The Human Neurotransmitters Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Department of Physiology, Monash University, Melbourne, VIC, Australia. · Neurovascular Hypertension & Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. · Neuropharmacology Laboratories, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC, Australia. · The Department of Pharmacology, Monash University, Melbourne, VIC, Australia. · Pubmed 27046647
2016
  • aDobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Western Australia bDepartment of Cardiology, Royal Perth Hospital and Fiona Stanley Hospital, Perth cNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 27356001
  • School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Western Australia, Australia; · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; and. · Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 27630063
  • Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. Electronic address: · Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Kardiologie, Universitäres Herzzentrum, Universitätsspital, Zürich, Switzerland. · Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany. · Department of Nephrology, University Medical Center, Utrecht, the Netherlands. · Medizinische Klinik III, Universitätsklinikum Heidelberg, Germany. · Medizinische Klinik I, Abteilung für Kardiologie und Angiologie, Universitätsklinikum, Gießen, Germany. · Baker IDI Heart and Diabetes Research Institute, Melbourne, Australia. · Angiologie, Universitätsherzzentrum, Bad Krozingen, Germany. · Galway University Hospitals, Ireland. · Department of Cardiology, University Medical Center, Utrecht, the Netherlands. · Institute for Medical Engineering and Science, MIT, Cambridge MA and Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 27617388
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · The Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · William Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK. · Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Cardiology, University of Giessen, Giessen, Germany. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Department of Nephrology and Hypertension, University Hospital of Erlangen, Erlangen, Germany. · Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Cardiology, Heartcenter Catharina Hospital, Eindhoven, The Netherlands. · Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Cardiovascular Research Centre, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia. · Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 27105858
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Atherosclerosis & Vascular Biology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neuropharmacology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. Electronic address: · Pubmed 26432488
2015
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. Electronic address: · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Pubmed 25889337
  • School of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Electronic address: · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 25620017
2014
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria 8008, Australia. · Pubmed 24470460
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne Victoria 8008, Australia. · Pubmed 24324047
  • 1] Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [2] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia [3] Department of Cardiology, Royal Melbourne Hospital, Parkville, Victoria, Australia. · 1] Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [2] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia. · Pubmed 24088716
  • Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany · Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany Klinik für Innere Medizin/Kardiologie, Deutsches Herzzentrum Berlin, Berlin, Germany. · Klinik für Innere Medizin/Kardiologie, Deutsches Herzzentrum Berlin, Berlin, Germany. · Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 24603307
  • Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC, Australia. Electronic address: · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia. · Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA. · Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany. · Prairie Heart Institute at St John's Hospital, Springfield, IL, USA. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 24210779
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225255
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225252
  • Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia · Universitätsklinium des Saarlandes, Homburg/Saar, Germany. · CardioVaskuläres Centrum, Frankfurt, Germany. · Department of Nephrology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany. · Department of Nephrology, Hypertension of the University Hospital, Clinical Research Competence Center of Hypertension and Vascular Medicine, Erlangen, Germany. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. · Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia. · Pubmed 24898552
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Vic 8008, Australia. · Pubmed 24566956
  • Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa. · Department of Psychology, Technische Universität Dresden, Dresden, Germany. · Human Neurotransmitters and Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · 1] Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa [2] Department of Epidemiology and Public Health, University College of London, London, UK. · Pubmed 24284381
  • Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. Electronic address: · Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA. · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia. · Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 24881987
  • Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg/Saar, Germany. · Universität Erlangen-Nürnberg, Medizinische Klinik 4, Nürnberg, Germany. · Universitätsklinikum Klinik für Nephrologie, Düsseldorf, Germany. · Medizinische Klinik II, Universität Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Städtisches Klinikum München GmbH, München, Germany. · Klinik III für Innere Medizin, Universität zu Köln, Köln, Germany. · Herz-Zentrum Bad Krotzingen, Bad Krotzingen, Germany. · Universitätsklinikum Tübingen Medizinische UNI-Klinik und Poliklinik Abt. Innere Medizin III, Tübingen, Germany. · Medizinische Klinik 4, Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen, Germany. · Uni-Klinikum Heidelberg, Medizinische Klinik, Innere Medizin III, Kardiologie, Angiologie und Pneumologie, Heidelberg, Germany. · Ohio State University, Columbus, OH. · Monash University/Alfred Hospital, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Victoria, Australia. · Pubmed 24842939
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia. · 1] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia [2] Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [3] Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24257512
2013
  • Neurovascular Hypertension & Kidney Disease and Human Neurotransmitters Laboratories Baker IDI Heart & Diabetes Institute, Alfred Hospital, Melbourne, Australia; Heart Centre, Alfred Hospital, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Pubmed 23453868
  • Baker IDI Heart & Diabetes Institute/Heart Centre, Alfred Hospital and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address: · Pubmed 24021387
2012
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne, Victoria, 8008, Australia. · Pubmed 22457244
2011
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, Australia. · Pubmed 21394087
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, Australia. · Pubmed 21442159
2010
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria, 8008, Australia. · Pubmed 20509010
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, St. Kilda Road Central, Melbourne, Victoria 8008, Australia. · Pubmed 20425157
2009
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St. Kilda Rd Central, Melbourne, Victoria 8008, Australia. · Pubmed 19822798
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart Research Institute, P.O. Box 6492 St. Kilda Road Central, Melbourne VIC 8008, Australia. · Pubmed 18799718
  • Neurovascular Hypertension and Kidney Disease Laboratory, Alfred and Baker Hypertension Network, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 8008, Australia. · Pubmed 19594440
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 19155773
2017
  • From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · Pubmed 27956575
  • aUniversitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, GermanybDepartment of Medicine, University of Milano-Bicocca, ItalycDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, PolanddHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, SpaineFaculty of Medicine, Monash University, Baker IDI Heart and Diabetes Institute, Melbourne and Dobney Hypertension Centre, School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliafDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanygInstitute of Cardiovascular Science, University College London, London, UK. · Pubmed 27906840
2015
  • aHypertension-24 h ABPM ESH Center of Excellence, Papageorgiou Hospital, Aristotle University Thessaloniki, Greece bDepartment of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden cDepartment of Health Science, University of Milano-Bicocca, Milano, Italy and Istituto di Ricerche a Carattere Scientifico Multimedica IRCCS, Sesto San Giovanni, Milan dIstituto Auxologico Italiano, Milano, Italy eUniversity of Valencia and INCLIVA Research Institute and CIBERobn, Madrid, Spain fExperimental and Clinical Research Center, Kooperation zwischen dem Max-Delbrück-Centrum für Molekulare Medizin und der Medizinischen Fakultät der Charité, Berlin gAbteilung für Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen hInstitute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany i1st Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, Greece jDepartment of Medicine, Debrecen University, Hungary kSchool of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 26103132
  • aHuman Neurotransmitters bNeurovascular Hypertension and Kidney Disease cNeuropharmacology Laboratories, Baker IDI Heart and Diabetes Institute dFaculty of Medicine, Nursing and Health Sciences eDepartment of Physiology fPrimary Care Research, Monash University, Melbourne gRoyal Perth Hospital Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 26259120
  • Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Campus, University of Western Australia, Perth, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. · Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. Electronic address: · Pubmed 25638699
  • From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.). · From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.). · Pubmed 25403610
2014
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. · Pubmed 24275767
  • *Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 24020446
  • Laboratories of Human Neurotransmitters (N.E.S., M.T.G., C.L.S., N.E., G.W.L., K.R., J.B.D., E.A.L.), Cardiovascular Nutrition (P.J.N.), and Neurovascular Hypertension and Kidney Disease (P.M., M.P.S.) and Alfred Baker Medical Unit (S.K., C.W.), Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 8008, Australia; Faculty of Medicine, Nursing, and Health Sciences (G.W.L., M.P.S.) and the Departments of Physiology (E.A.L.) and Primary Health Care (J.B.D.), Monash University, Melbourne, Victoria 3800, Australia; and the Department of Physiology (E.A.L.), University of Melbourne, Melbourne 3010, Australia. · Pubmed 24937541
  • From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · Pubmed 24732891
  • Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 24436322
2013
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dDepartment of Physiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24100214
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 23732145
  • aNeurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia bDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland cHeart Centre Alfred Hospital dDepartment of Epidemiology & Preventive Medicine eFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia fDepartment of Medicine and Cardiology, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota gMedtronic ARDIAN Inc., Mountain View, California, USA hUniversitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Pubmed 23697964
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 8008, Australia. · Pubmed 23172929
2012
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 23244359
  • Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia. · Pubmed 23248063
  • Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Vic 8008, Australia. · Pubmed 23169801
  • Human Neurotransmitters, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 23071129
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 22595301
2011
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia. · Pubmed 21714604
2010
  • Nucleus Network Ltd, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 20339374
  • Human Neurotransmitters/Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 20125037
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 21148350
  • Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road, Central Melbourne, VIC 8008, Australia. · Pubmed 21093036
  • Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia. · Pubmed 20625075
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 20185633
  • Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 20139772
2009
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Alfred Hospital, Melbourne, Australia. · Pubmed 19942842
2008
  • Baker Heart Research Institute, Melbourne, Victoria, Australia. · Pubmed 18307749
  • Baker Heart Research Institute, Melbourne, Australia. · Pubmed 19120127
2007
  • Human Neurotransmitters Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia. · Pubmed 17909120
  • Human Neurotransmitters Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia. · Pubmed 17563563
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 115 total) written by Markus P. Schlaich about Hypertension:

  • Obesity Paradox in Hypertension: Is This Because Sympathetic Activation in Obesity-Hypertension Takes a Benign Form? 2018
  • Hypertension on the ROX: Durable Blood Pressure Lowering With Central Iliac Arteriovenous Anastomosis. 2017
  • Renal Denervation After the SPYRAL HTN-OFF MED Trial: Putting a Complex Study Into Context. 2017
  • Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet? 2017
  • Catheter-Based Renal Denervation Exacerbates Blood Pressure Fall During Hemorrhage. 2017
  • Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk. 2017
  • Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry. 2017
  • Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation. 2017
  • A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. 2017
  • Guideline for the diagnosis and management of hypertension in adults - 2016. 2016
Show List of Full Article Records
Google Searches

Learn more about Markus P. Schlaich using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Western Australia
Swinburne University of Technology
Baker IDI Heart and Diabetes Institute
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Western Australia
2018
  • From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · Pubmed 29158358
2017
  • From the Dobney Hypertension Centre, School of Medicine (M.P.S., O.A.), Department of Cardiology (M.P.S.), and Department of Nephrology (M.P.S.), Royal Perth Hospital Unit, University of Western Australia; and Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.P.S., Y.S.). · From the Dobney Hypertension Centre, School of Medicine (M.P.S., O.A.), Department of Cardiology (M.P.S.), and Department of Nephrology (M.P.S.), Royal Perth Hospital Unit, University of Western Australia; and Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia (M.P.S., Y.S.). · Pubmed 29061721
  • From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 29038200
  • Dobney Hypertension Centre, Faculty of Health and Medical Sciences, School of Medicine-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Department of Nephrology, Royal Perth Hospital, Perth, Australia. · Dobney Hypertension Centre, Faculty of Health and Medical Sciences, School of Medicine-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Department of Nephrology, Royal Perth Hospital, Perth, Australia. · Dobney Chair in Clinical Research, School of Medicine and Pharmacology - Royal Perth Hospital Unit, The University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia. · Pubmed 28349377
  • Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Pubmed 28231948
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Heart Centre Alfred Hospital, Melbourne, Victoria, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia. · Pubmed 27604660
  • The Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Central Clinical School, Faculty of Medicine, Monash University, Melbourne, VIC, Australia. · The Human Neurotransmitters Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Department of Physiology, Monash University, Melbourne, VIC, Australia. · Neurovascular Hypertension & Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. · Neuropharmacology Laboratories, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC, Australia. · The Department of Pharmacology, Monash University, Melbourne, VIC, Australia. · Pubmed 27046647
2016
  • aDobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Western Australia bDepartment of Cardiology, Royal Perth Hospital and Fiona Stanley Hospital, Perth cNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 27356001
  • Dobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth. · Dobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth; Department of Cardiology, Royal Perth Hospital, Perth, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth; Department of Cardiology, Royal Perth Hospital, Perth, Australia. Electronic address: · Pubmed 27671866
  • School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Western Australia, Australia; · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; and. · Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 27630063
  • Department of Medical Science, Internal Medicine Ward and Hypertension Centre Azienda Ospedaliera, Treviglio, BG, Italy. · Dobney Hypertension Centre School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia. · Dobney Hypertension Centre School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia. · Pubmed 26781253
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · The Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · William Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK. · Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Cardiology, University of Giessen, Giessen, Germany. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Department of Nephrology and Hypertension, University Hospital of Erlangen, Erlangen, Germany. · Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Cardiology, Heartcenter Catharina Hospital, Eindhoven, The Netherlands. · Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Cardiovascular Research Centre, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia. · Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 27105858
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Atherosclerosis & Vascular Biology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neuropharmacology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. Electronic address: · Pubmed 26432488
  • Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia Baker IDI Heart and Diabetes Institute, Melbourne, Australia · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia. · Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia. · School of Medicine and Pharmacology, Royal Perth Hospital Unit, The University of Western Australia, Australia. · Discipline of General Practice, University of Adelaide, Australia. · Departments of Medicine and Cardiology, The University of Melbourne, Austin Health, Australia. · Geelong Cardiology Research Department, Deakin University, Australia. · School of Medicine, University of Queensland, Brisbane, Australia. · Novartis Pharmaceuticals Australia Ltd, Sydney, Australia. · Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 26088568
2015
  • School of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Electronic address: · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 25620017
2017
  • From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · Pubmed 27956575
  • aUniversitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, GermanybDepartment of Medicine, University of Milano-Bicocca, ItalycDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, PolanddHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, SpaineFaculty of Medicine, Monash University, Baker IDI Heart and Diabetes Institute, Melbourne and Dobney Hypertension Centre, School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliafDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanygInstitute of Cardiovascular Science, University College London, London, UK. · Pubmed 27906840
2016
  • aUniversitätskliniken des Saarlandes und Universität des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany bUniversitätsklinik für Innere Medizin II, Kardiologie, Internistische Intensivmedizin und Notaufnahme, SALK - Paracelsus Universität Salzburg, Salzburg, Austria cDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland dHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain eDobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia fMedtronic, Santa Rosa, California, USA gUniversität Erlangen-Nürnberg, Medizinische Klinik 4, Nürnberg, Germany hInstitute of Cardiovascular Science and NHR Biomedical Research Centre, University College London, London, UK iKlinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, Germany jDepartment of Cardiology and Angiology, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Freiburg, Germany kCentro di Fisiologia Clinica e Ipertensione, University of Milano-Bicocca, Milan, Italy. · Pubmed 27755390
2015
  • aHypertension-24 h ABPM ESH Center of Excellence, Papageorgiou Hospital, Aristotle University Thessaloniki, Greece bDepartment of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden cDepartment of Health Science, University of Milano-Bicocca, Milano, Italy and Istituto di Ricerche a Carattere Scientifico Multimedica IRCCS, Sesto San Giovanni, Milan dIstituto Auxologico Italiano, Milano, Italy eUniversity of Valencia and INCLIVA Research Institute and CIBERobn, Madrid, Spain fExperimental and Clinical Research Center, Kooperation zwischen dem Max-Delbrück-Centrum für Molekulare Medizin und der Medizinischen Fakultät der Charité, Berlin gAbteilung für Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen hInstitute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany i1st Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, Greece jDepartment of Medicine, Debrecen University, Hungary kSchool of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 26103132
  • School of Medicine and Pharmacology - Royal Perth Hospital Unit, The University of Western Australia, Level 3 MRF Building, Rear 50 Murray Street, Perth, WA, 6000 MDBP: M570, Australia, · Pubmed 26070453
  • aHuman Neurotransmitters bNeurovascular Hypertension and Kidney Disease cNeuropharmacology Laboratories, Baker IDI Heart and Diabetes Institute dFaculty of Medicine, Nursing and Health Sciences eDepartment of Physiology fPrimary Care Research, Monash University, Melbourne gRoyal Perth Hospital Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 26259120
  • aMenzies Institute for Medical Research, University of Tasmania, Hobart bBaker IDI Heart and Diabetes Institute, Melbourne cMonash University, Clayton, Victoria dEndocrine Hypertension Research Centre, University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane, Queensland eSchool of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth fCentre for Research in Evidence Based Practice, Bond University, Queensland, Australia. · Pubmed 26136205
  • From the Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany (M.B., F.M, C.U.); Department of Internal Medicine II, Paracelsus University Salzburg, Salzburg, Austria (U.C.H.);Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (K.N.); Global Clinical Research, Coronary and Structural Heart Disease Management, Medtronic Inc, Santa Rosa, CA (M.N.); Institute of Research & Hypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain (L.R.); School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia (M.P.S.); Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany (R.E.S.); Cardiovascular Research Centre, Interventional Cardiology, St. Vincent's Hospital, Melbourne, Australia (R.W.); Institute of Cardiovascular Sciences, University College London (UCL), National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, United Kingdom (B.W.); Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, Germany (U.Z.); Department of Cardiology and Angiology I, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Freiburg, Germany (A.Z.); and IRCCS Istituto Auxologico Italiano, Center of Epidemiology and Clinical Trials, University of Milano-Bicocca, Milan, Italy (G.M.). · From the Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany (M.B., F.M, C.U.); Department of Internal Medicine II, Paracelsus University Salzburg, Salzburg, Austria (U.C.H.);Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (K.N.); Global Clinical Research, Coronary and Structural Heart Disease Management, Medtronic Inc, Santa Rosa, CA (M.N.); Institute of Research & Hypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain (L.R.); School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Australia (M.P.S.); Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany (R.E.S.); Cardiovascular Research Centre, Interventional Cardiology, St. Vincent's Hospital, Melbourne, Australia (R.W.); Institute of Cardiovascular Sciences, University College London (UCL), National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, United Kingdom (B.W.); Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, Germany (U.Z.); Department of Cardiology and Angiology I, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Freiburg, Germany (A.Z.); and IRCCS Istituto Auxologico Italiano, Center of Epidemiology and Clinical Trials, University of Milano-Bicocca, Milan, Italy (G.M.). · Pubmed 25691618
  • Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Campus, University of Western Australia, Perth, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. · Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. Electronic address: · Pubmed 25638699
Swinburne University of Technology
2018
  • From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · From the Baker Heart and Diabetes Institute, Melbourne, Australia (M.E., J.D., C.I.S.); Swinburne University of Technology, Melbourne, Australia (G.L., E.L.); and School of Medicine, Royal Perth Hospital Unit, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Perth (M.S.). · Pubmed 29158358
Baker IDI Heart and Diabetes Institute
2017
  • From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · From the Dobney Hypertension Centre, School of Medicine-Royal Perth Hospital Unit, University of Western Australia (M.P.S.); Department of Cardiology (M.P.S.) and Department of Nephrology (M.P.S.), Royal Perth Hospital, Australia; and Neurovascular Hypertension and Kidney Disease Laboratory (M.P.S., M.D.E.) and Human Neurotransmitter Laboratory (M.D.E.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 29038200
  • Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Cardiovascular Program, Monash Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Victoria, Australia. · The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Pubmed 28231948
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Heart Centre Alfred Hospital, Melbourne, Victoria, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia. · Pubmed 27604660
  • The Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Central Clinical School, Faculty of Medicine, Monash University, Melbourne, VIC, Australia. · The Human Neurotransmitters Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Department of Physiology, Monash University, Melbourne, VIC, Australia. · Neurovascular Hypertension & Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. · Neuropharmacology Laboratories, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC, Australia. · The Department of Pharmacology, Monash University, Melbourne, VIC, Australia. · Pubmed 27046647
2016
  • aDobney Hypertension Centre, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Western Australia bDepartment of Cardiology, Royal Perth Hospital and Fiona Stanley Hospital, Perth cNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 27356001
  • School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Western Australia, Australia; · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; and. · Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 27630063
  • Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. Electronic address: · Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Kardiologie, Universitäres Herzzentrum, Universitätsspital, Zürich, Switzerland. · Kardiologie, Asklepios Klinik St. Georg, Hamburg, Germany. · Department of Nephrology, University Medical Center, Utrecht, the Netherlands. · Medizinische Klinik III, Universitätsklinikum Heidelberg, Germany. · Medizinische Klinik I, Abteilung für Kardiologie und Angiologie, Universitätsklinikum, Gießen, Germany. · Baker IDI Heart and Diabetes Research Institute, Melbourne, Australia. · Angiologie, Universitätsherzzentrum, Bad Krozingen, Germany. · Galway University Hospitals, Ireland. · Department of Cardiology, University Medical Center, Utrecht, the Netherlands. · Institute for Medical Engineering and Science, MIT, Cambridge MA and Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 27617388
  • Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · The Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · William Harvey Research Institute, Barts NIHR Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK. · Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Cardiology, University of Giessen, Giessen, Germany. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Department of Nephrology and Hypertension, University Hospital of Erlangen, Erlangen, Germany. · Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Cardiology, Heartcenter Catharina Hospital, Eindhoven, The Netherlands. · Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. · Cardiovascular Research Centre, University of Adelaide, Royal Adelaide Hospital, Adelaide, Australia. · Department of Nephrology and Hypertension, University Medical Center Utrecht, Room F03.220, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Pubmed 27105858
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Atherosclerosis & Vascular Biology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neuropharmacology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. Electronic address: · Pubmed 26432488
2015
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. Electronic address: · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Pubmed 25889337
  • School of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Crawley, WA 6009, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Australia. Electronic address: · Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 25620017
2014
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria 8008, Australia. · Pubmed 24470460
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central, Melbourne Victoria 8008, Australia. · Pubmed 24324047
  • 1] Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [2] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia [3] Department of Cardiology, Royal Melbourne Hospital, Parkville, Victoria, Australia. · 1] Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [2] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia. · Pubmed 24088716
  • Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany · Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany Klinik für Innere Medizin/Kardiologie, Deutsches Herzzentrum Berlin, Berlin, Germany. · Klinik für Innere Medizin/Kardiologie, Deutsches Herzzentrum Berlin, Berlin, Germany. · Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 24603307
  • Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC, Australia. Electronic address: · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia. · Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA. · Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany. · Prairie Heart Institute at St John's Hospital, Springfield, IL, USA. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 24210779
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225255
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225252
  • Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia · Universitätsklinium des Saarlandes, Homburg/Saar, Germany. · CardioVaskuläres Centrum, Frankfurt, Germany. · Department of Nephrology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany. · Department of Nephrology, Hypertension of the University Hospital, Clinical Research Competence Center of Hypertension and Vascular Medicine, Erlangen, Germany. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. · Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia. · Pubmed 24898552
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Vic 8008, Australia. · Pubmed 24566956
  • Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa. · Department of Psychology, Technische Universität Dresden, Dresden, Germany. · Human Neurotransmitters and Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · 1] Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa [2] Department of Epidemiology and Public Health, University College of London, London, UK. · Pubmed 24284381
  • Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. Electronic address: · Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA. · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia. · Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 24881987
  • Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg/Saar, Germany. · Universität Erlangen-Nürnberg, Medizinische Klinik 4, Nürnberg, Germany. · Universitätsklinikum Klinik für Nephrologie, Düsseldorf, Germany. · Medizinische Klinik II, Universität Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. · Städtisches Klinikum München GmbH, München, Germany. · Klinik III für Innere Medizin, Universität zu Köln, Köln, Germany. · Herz-Zentrum Bad Krotzingen, Bad Krotzingen, Germany. · Universitätsklinikum Tübingen Medizinische UNI-Klinik und Poliklinik Abt. Innere Medizin III, Tübingen, Germany. · Medizinische Klinik 4, Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen, Germany. · Uni-Klinikum Heidelberg, Medizinische Klinik, Innere Medizin III, Kardiologie, Angiologie und Pneumologie, Heidelberg, Germany. · Ohio State University, Columbus, OH. · Monash University/Alfred Hospital, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Victoria, Australia. · Pubmed 24842939
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia. · 1] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia [2] Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [3] Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24257512
2013
  • Neurovascular Hypertension & Kidney Disease and Human Neurotransmitters Laboratories Baker IDI Heart & Diabetes Institute, Alfred Hospital, Melbourne, Australia; Heart Centre, Alfred Hospital, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Pubmed 23453868
  • Baker IDI Heart & Diabetes Institute/Heart Centre, Alfred Hospital and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address: · Pubmed 24021387
2012
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, P.O. Box 6492, St. Kilda Road Central, Melbourne, Victoria, 8008, Australia. · Pubmed 22457244
2011
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, Australia. · Pubmed 21394087
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC 8008, Australia. · Pubmed 21442159
2010
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria, 8008, Australia. · Pubmed 20509010
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, St. Kilda Road Central, Melbourne, Victoria 8008, Australia. · Pubmed 20425157
2009
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St. Kilda Rd Central, Melbourne, Victoria 8008, Australia. · Pubmed 19822798
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker Heart Research Institute, P.O. Box 6492 St. Kilda Road Central, Melbourne VIC 8008, Australia. · Pubmed 18799718
  • Neurovascular Hypertension and Kidney Disease Laboratory, Alfred and Baker Hypertension Network, Baker IDI Heart and Diabetes Institute, Melbourne, VIC 8008, Australia. · Pubmed 19594440
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 19155773
2017
  • From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · Pubmed 27956575
  • aUniversitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, GermanybDepartment of Medicine, University of Milano-Bicocca, ItalycDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, PolanddHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, SpaineFaculty of Medicine, Monash University, Baker IDI Heart and Diabetes Institute, Melbourne and Dobney Hypertension Centre, School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliafDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanygInstitute of Cardiovascular Science, University College London, London, UK. · Pubmed 27906840
2015
  • aHypertension-24 h ABPM ESH Center of Excellence, Papageorgiou Hospital, Aristotle University Thessaloniki, Greece bDepartment of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden cDepartment of Health Science, University of Milano-Bicocca, Milano, Italy and Istituto di Ricerche a Carattere Scientifico Multimedica IRCCS, Sesto San Giovanni, Milan dIstituto Auxologico Italiano, Milano, Italy eUniversity of Valencia and INCLIVA Research Institute and CIBERobn, Madrid, Spain fExperimental and Clinical Research Center, Kooperation zwischen dem Max-Delbrück-Centrum für Molekulare Medizin und der Medizinischen Fakultät der Charité, Berlin gAbteilung für Nephrologie und Hypertensiologie, Universitätsklinikum Erlangen, Erlangen hInstitute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany i1st Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, Greece jDepartment of Medicine, Debrecen University, Hungary kSchool of Medicine and Pharmacology Royal Perth Hospital Unit, University of Western Australia, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 26103132
  • aHuman Neurotransmitters bNeurovascular Hypertension and Kidney Disease cNeuropharmacology Laboratories, Baker IDI Heart and Diabetes Institute dFaculty of Medicine, Nursing and Health Sciences eDepartment of Physiology fPrimary Care Research, Monash University, Melbourne gRoyal Perth Hospital Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 26259120
  • Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Campus, University of Western Australia, Perth, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. · Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. Electronic address: · Pubmed 25638699
  • From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.). · From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.). · Pubmed 25403610
2014
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. · Pubmed 24275767
  • *Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 24020446
  • Laboratories of Human Neurotransmitters (N.E.S., M.T.G., C.L.S., N.E., G.W.L., K.R., J.B.D., E.A.L.), Cardiovascular Nutrition (P.J.N.), and Neurovascular Hypertension and Kidney Disease (P.M., M.P.S.) and Alfred Baker Medical Unit (S.K., C.W.), Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 8008, Australia; Faculty of Medicine, Nursing, and Health Sciences (G.W.L., M.P.S.) and the Departments of Physiology (E.A.L.) and Primary Health Care (J.B.D.), Monash University, Melbourne, Victoria 3800, Australia; and the Department of Physiology (E.A.L.), University of Melbourne, Melbourne 3010, Australia. · Pubmed 24937541
  • From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · Pubmed 24732891
  • Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 24436322
2013
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dDepartment of Physiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24100214
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 23732145
  • aNeurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia bDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland cHeart Centre Alfred Hospital dDepartment of Epidemiology & Preventive Medicine eFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia fDepartment of Medicine and Cardiology, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota gMedtronic ARDIAN Inc., Mountain View, California, USA hUniversitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Pubmed 23697964
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 8008, Australia. · Pubmed 23172929
2012
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 23244359
  • Baker IDI Heart and Diabetes Institute, 75 Commercial Rd, Melbourne, Victoria 3004, Australia. · Pubmed 23248063
  • Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Vic 8008, Australia. · Pubmed 23169801
  • Human Neurotransmitters, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 23071129
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Pubmed 22595301
2011
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia. · Pubmed 21714604
2010
  • Nucleus Network Ltd, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 20339374
  • Human Neurotransmitters/Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 20125037
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 21148350
  • Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road, Central Melbourne, VIC 8008, Australia. · Pubmed 21093036
  • Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia. · Pubmed 20625075
  • Baker IDI Heart and Diabetes Institute, Melbourne, Australia. · Pubmed 20185633
  • Human Neurotransmitters Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Pubmed 20139772
2009
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Alfred Hospital, Melbourne, Australia. · Pubmed 19942842
2008
  • Baker Heart Research Institute, Melbourne, Victoria, Australia. · Pubmed 18307749
  • Baker Heart Research Institute, Melbourne, Australia. · Pubmed 19120127
2007
  • Human Neurotransmitters Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia. · Pubmed 17909120
  • Human Neurotransmitters Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia. · Pubmed 17563563
Monash University
2017
  • The Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Central Clinical School, Faculty of Medicine, Monash University, Melbourne, VIC, Australia. · The Human Neurotransmitters Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · The Department of Physiology, Monash University, Melbourne, VIC, Australia. · Neurovascular Hypertension & Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Dobney Hypertension Centre, School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. · Neuropharmacology Laboratories, Baker IDI Heart and Diabetes Research Institute, Melbourne, VIC, Australia. · The Department of Pharmacology, Monash University, Melbourne, VIC, Australia. · Pubmed 27046647
2016
  • School of Medicine and Pharmacology-Royal Perth Hospital Unit, The University of Western Australia, Perth, Western Australia, Australia; · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; and. · Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 27630063
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia; Atherosclerosis & Vascular Biology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neuropharmacology Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of WA, Perth, Australia; Department of Epidemiology & Preventive Medicine, Monash University, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. Electronic address: · Pubmed 26432488
2014
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225255
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225252
  • Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia · Universitätsklinium des Saarlandes, Homburg/Saar, Germany. · CardioVaskuläres Centrum, Frankfurt, Germany. · Department of Nephrology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany. · Department of Nephrology, Hypertension of the University Hospital, Clinical Research Competence Center of Hypertension and Vascular Medicine, Erlangen, Germany. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. · Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia. · Pubmed 24898552
  • Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa. · Department of Psychology, Technische Universität Dresden, Dresden, Germany. · Human Neurotransmitters and Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · 1] Hypertension in Africa Research Team (HART), Faculty of Health Sciences, North-West University, Potchefstroom, South Africa [2] Department of Epidemiology and Public Health, University College of London, London, UK. · Pubmed 24284381
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia. · 1] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia [2] Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [3] Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24257512
2013
  • Neurovascular Hypertension & Kidney Disease and Human Neurotransmitters Laboratories Baker IDI Heart & Diabetes Institute, Alfred Hospital, Melbourne, Australia; Heart Centre, Alfred Hospital, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Pubmed 23453868
  • Baker IDI Heart & Diabetes Institute/Heart Centre, Alfred Hospital and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address: · Pubmed 24021387
2017
  • From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · From the Atherothrombosis and Vascular Biology (M.T.K.Z., J.R., B.L., N.M.H., S.U.E., U.F., K.P.) and Neurovascular Hypertension and Kidney Disease Laboratory (D.H., P.M., Y.S., N.E., R.L., G.W.L., M.D.E., J.D., L.H., M.P.S.), Baker IDI Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne (M.T.K.Z., N.M.H., M.P.S., K.P.); Dobney Hypertension Centre, School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Australia (D.H., P.M., M.P.S.); and Department of Plastic and Hand Surgery, University Medical Centre, Freiburg, Germany (S.U.E.). · Pubmed 27956575
  • aUniversitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, GermanybDepartment of Medicine, University of Milano-Bicocca, ItalycDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, PolanddHypertension Unit, Department of Nephrology, Hospital 12 de Octubre, Madrid, SpaineFaculty of Medicine, Monash University, Baker IDI Heart and Diabetes Institute, Melbourne and Dobney Hypertension Centre, School of Medicine and Pharmacology - Royal Perth Hospital Unit, University of Western Australia, Perth, AustraliafDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanygInstitute of Cardiovascular Science, University College London, London, UK. · Pubmed 27906840
2015
  • aHuman Neurotransmitters bNeurovascular Hypertension and Kidney Disease cNeuropharmacology Laboratories, Baker IDI Heart and Diabetes Institute dFaculty of Medicine, Nursing and Health Sciences eDepartment of Physiology fPrimary Care Research, Monash University, Melbourne gRoyal Perth Hospital Unit, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia. · Pubmed 26259120
  • Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Campus, University of Western Australia, Perth, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. · Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. Electronic address: · Pubmed 25638699
  • From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.). · From the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia (L.C.B., S.T.Y., R.R., C.N.M.); Baker IDI Heart and Diabetes Institute, Central Clinical School Monash University, Melbourne, Victoria, Australia (M.P.S., G.W.L.); and Department of Physiology, Cardiovascular Division, Federal University of São Paulo, São Paulo, Brazil (E.E.N.). · Pubmed 25403610
2014
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. · Pubmed 24275767
  • Laboratories of Human Neurotransmitters (N.E.S., M.T.G., C.L.S., N.E., G.W.L., K.R., J.B.D., E.A.L.), Cardiovascular Nutrition (P.J.N.), and Neurovascular Hypertension and Kidney Disease (P.M., M.P.S.) and Alfred Baker Medical Unit (S.K., C.W.), Baker IDI Heart and Diabetes Institute, Melbourne, Victoria 8008, Australia; Faculty of Medicine, Nursing, and Health Sciences (G.W.L., M.P.S.) and the Departments of Physiology (E.A.L.) and Primary Health Care (J.B.D.), Monash University, Melbourne, Victoria 3800, Australia; and the Department of Physiology (E.A.L.), University of Melbourne, Melbourne 3010, Australia. · Pubmed 24937541
  • From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · Pubmed 24732891
2013
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dDepartment of Physiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24100214
  • Centre of Cardiovascular Research & Education (CCRE) in Therapeutics, Monash University/Alfred Hospital, Melbourne, Australia. · Pubmed 23819768
  • aNeurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia bDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland cHeart Centre Alfred Hospital dDepartment of Epidemiology & Preventive Medicine eFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia fDepartment of Medicine and Cardiology, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota gMedtronic ARDIAN Inc., Mountain View, California, USA hUniversitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Pubmed 23697964
2011
  • Monash Centre of Cardiovascular Research & Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. · Pubmed 21247927
  • Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. · Pubmed 21242507
2009
  • Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Pubmed 19332353
Alfred Hospital
2017
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · School of Medicine and Pharmacology-Royal Perth Hospital Unit, University of Western Australia, Perth, Western Australia, Australia. · Heart Centre Alfred Hospital, Melbourne, Victoria, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australia. · Pubmed 27604660
2015
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. Electronic address: · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia. · Heart Centre Alfred Hospital, Melbourne, Australia. · Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health & Preventive Medicine, Monash University, Melbourne Australia. · Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Australia; Heart Centre Alfred Hospital, Melbourne, Australia. · Pubmed 25889337
2014
  • 1] Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [2] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia [3] Department of Cardiology, Royal Melbourne Hospital, Parkville, Victoria, Australia. · 1] Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [2] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia. · Pubmed 24088716
  • Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, VIC, Australia. Electronic address: · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia. · Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA. · Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany. · Prairie Heart Institute at St John's Hospital, Springfield, IL, USA. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 24210779
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225255
  • Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia. · Neurovascular Hypertension & Kidney Disease, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia. · Pubmed 25225252
  • Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. Electronic address: · Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA. · Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, VIC, Australia. · Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinium des Saarlandes, Homburg, Germany. · Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia. · Pubmed 24881987
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia. · 1] Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia [2] Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia [3] Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24257512
2013
  • Neurovascular Hypertension & Kidney Disease and Human Neurotransmitters Laboratories Baker IDI Heart & Diabetes Institute, Alfred Hospital, Melbourne, Australia; Heart Centre, Alfred Hospital, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia. Electronic address: · Pubmed 23453868
  • Baker IDI Heart & Diabetes Institute/Heart Centre, Alfred Hospital and Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address: · Pubmed 24021387
2011
  • Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute and Heart Centre, Alfred Hospital, Melbourne, Australia. · Pubmed 21394087
2015
  • Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; School of Medicine and Pharmacology-Royal Perth Hospital Campus, University of Western Australia, Perth, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. · Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. · Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Cardiology Department, Royal Melbourne Hospital, Victoria, Australia; Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Victoria, Australia. Electronic address: · Pubmed 25638699
2014
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Australia. · Pubmed 24275767
  • From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., P.M., E.A.L., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland (D.H., K.N.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); and Department of Physiology, Faculty of Medicine, Nursing and Health Sciences (E.A.L., G.W.L., M.P.S.) and Department of Epidemiology and Preventive Medicine (H.K.), Monash University, Melbourne, Australia. · Pubmed 24732891
2013
  • aNeurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute bSchool of Public Health and Preventive Medicine, Monash University cHeart Centre Alfred Hospital dDepartment of Physiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia. · Pubmed 24100214
  • Centre of Cardiovascular Research & Education (CCRE) in Therapeutics, Monash University/Alfred Hospital, Melbourne, Australia. · Pubmed 23819768
  • aNeurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia bDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland cHeart Centre Alfred Hospital dDepartment of Epidemiology & Preventive Medicine eFaculty of Medicine, Nursing and Health Sciences and Department of Physiology, Monash University, Melbourne, Victoria, Australia fDepartment of Medicine and Cardiology, Hennepin County Medical Center, University of Minnesota, Minneapolis, Minnesota gMedtronic ARDIAN Inc., Mountain View, California, USA hUniversitätsklinikum des Saarlandes, Homburg/Saar, Germany. · Pubmed 23697964
2011
  • Monash Centre of Cardiovascular Research & Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, VIC 3004, Australia. · Pubmed 21247927
  • Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. · Pubmed 21242507
2009
  • Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute and Alfred Hospital, Melbourne, Australia. · Pubmed 19942842
Unspecified
2016
  • Royal Adelaide Hospital, Adelaide, SA · Flinders Medical Centre, Flinders University, Adelaide, SA. · The George Institute for Global Health, Sydney, NSW. · Princess Alexandra Hospital, Brisbane, QLD. · Australian Prescriber, Canberra, ACT. · Queensland Research Centre for Peripheral Vascular Disease, James Cook University, Townsville, QLD. · University of Western Australia, Perth, WA. · Royal Adelaide Hospital, Adelaide, SA. · Pubmed 27456450
31 Other Locations Show
Yearly article counts 1811112113111011936
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.